HI
Last reporting period 31 Dec, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
5.613
Exchange
XLON - London Stock Exchange
4.7 B
Last period Assets ,USD
34%
Assets has increased in 5 years
What is Assets ?
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
See also Hikma Pharmaceuticals
Company Analysis
HIK.L valuation, rating, competitors, insights and company profile
Eyestock Rating
HIK.L financial analysis by Eyestock methodology
Valuation
HIK.L valuation using historical relative method
Statements
HIK.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HIK.L dividend yield and annual dividend
Assets are the book value of the company's tangible and intangible property, as well as cash and debt rights.
Hikma Pharmaceuticals`s Assets for the period ended 2023-12-31 are 4.7 B USD
